The WATCHMAN(TM) Left Atrial Appendage Closure Device from Boston Scientific is an implant used to block the left atrial appendage of the heart, a common area for blood clot formations in patients ...

Boston Scientific’s Watchman left atrial appendage (LAA) closure device to prevent stroke resulted in significantly less bleeding after an ablation procedure than taking blood thinners ...

MIDDLETOWN TOWNSHIP, PA — St. Mary Medical Center is the first hospital in Bucks County to implant the new Watchman FLX Pro Left Atrial Appendage Closure (LAAC) Device. The device features the ...

WATCHMAN FLX™ Pro Left Atrial Appendage Closure (LAAC) device, enhancing stroke prevention options for patients with non-valvular ...

establishing uniform coverage for percutaneous left atrial appendage closure (LAAC) devices such as the Watchman procedure. However, individuals must meet specific criteria. Learn more about the ...

Boston Scientific’s BSX robust expansion of operations across different geographies outside the United States is poised to help it grow in the upcoming quarters. The company’s Electrophysiology (EP) ...

Boston Scientific has reported positive three-year data from the OPTION global trial of the WATCHMAN FLX left atrial appendage closure (LAAC) device in individuals with atrial fibrillation ...

Key factors, such as long-lasting outcomes, effective LAA closure and a reduced need for blood-thinning ... Amulet LAA Occluder head-to-head with Boston Scientific's Watchman device. Five-year ...

The Watchman FLX device demonstrated superior safety and reduced bleeding risk compared to oral anticoagulation. Findings may prompt guideline changes, suggesting left atrial appendage closure as ...